Authors:
Engelholm, LH
Nielsen, BS
Dano, K
Behrendt, N
Citation: Lh. Engelholm et al., The urokinase receptor associated protein (uPARAP/Endo180): A novel internalization receptor connected to the plasminogen activation system, TREND CARD, 11(1), 2001, pp. 7-13
Authors:
Hoyer-Hansen, G
Pessara, U
Holm, A
Pass, J
Weidle, U
Dano, K
Behrendt, N
Citation: G. Hoyer-hansen et al., Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor, BIOCHEM J, 358, 2001, pp. 673-679
Authors:
Nielsen, BS
Sehested, M
Duun, S
Rank, F
Timshel, S
Rygaard, J
Johnsen, M
Dano, K
Citation: Bs. Nielsen et al., Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer, LAB INV, 81(11), 2001, pp. 1485-1501
Authors:
Engelholm, LH
Nielsen, BS
Netzel-Arnett, S
Solberg, H
Chen, XD
Garcia, JML
Lopez-Otin, C
Young, MF
Birkedal-Hansen, H
Dano, K
Lund, LR
Behrendt, N
Bugge, TH
Citation: Lh. Engelholm et al., The urokinase plasminogen activator receptor-associated Protein/Endo180 iscoexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis, LAB INV, 81(10), 2001, pp. 1403-1414
Authors:
Romer, J
Pyke, C
Lund, LR
Ralfkiaer, E
Dano, K
Citation: J. Romer et al., Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin, J INVES DER, 116(3), 2001, pp. 353-358
Authors:
Bajou, K
Masson, V
Gerard, RD
Schmitt, PM
Albert, V
Praus, M
Lund, LR
Frandsen, TL
Brunner, N
Dano, K
Fusenig, NE
Weidle, U
Carmeliet, G
Loskutoff, D
Collen, D
Carmeliet, P
Foidart, JM
Noel, AS
Citation: K. Bajou et al., The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies, J CELL BIOL, 152(4), 2001, pp. 777-784
Authors:
Nielsen, BS
Rank, F
Lopez, JM
Balbin, M
Vizoso, F
Lund, LR
Dano, K
Lopez-Otin, C
Citation: Bs. Nielsen et al., Collagenase-3 expression in breast myofibroblasts as a molecular marker oftransition of ductal carcinoma in situ lesions to invasive ductal carcinomas, CANCER RES, 61(19), 2001, pp. 7091-7100
Authors:
Ploug, M
Ostergaard, S
Gardsvoll, H
Kovalski, K
Holst-Hansen, C
Holm, A
Ossowski, L
Dano, K
Citation: M. Ploug et al., Peptide-derived antagonists of the urokinase receptor. Affinity maturationby combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation, BIOCHEM, 40(40), 2001, pp. 12157-12168
Authors:
Nielsen, BS
Lund, LR
Christensen, IJ
Johnsen, M
Usher, PA
Wulf-Andersen, L
Frandsen, TL
Dano, K
Gundersen, HJG
Citation: Bs. Nielsen et al., A precise and efficient stereological method for determining murine lung metastasis volumes, AM J PATH, 158(6), 2001, pp. 1997-2003
Authors:
Lund, LR
Bjorn, SF
Sternlicht, MD
Nielsen, BS
Solberg, H
Usher, PA
Osterby, R
Christensen, IJ
Stephens, RW
Bugge, TH
Dano, K
Werb, Z
Citation: Lr. Lund et al., Lactational competence and involution of the mouse mammary gland require plasminogen, DEVELOPMENT, 127(20), 2000, pp. 4481-4492
Authors:
Gardsvoll, H
Solberg, H
Dano, K
Hoyer-Hansen, G
Citation: H. Gardsvoll et al., Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization, J IMMUNOL M, 234(1-2), 2000, pp. 107-116
Authors:
Behrendt, N
Jensen, ON
Engelholm, LH
Mortz, E
Mann, M
Dano, K
Citation: N. Behrendt et al., A urokinase receptor-associated protein with specific collagen binding properties, J BIOL CHEM, 275(3), 2000, pp. 1993-2002
Authors:
Pedersen, AN
Christensen, IJ
Stephens, RW
Briand, P
Mouridsen, HT
Dano, K
Brunner, N
Citation: An. Pedersen et al., The complex between urokinase and its type-1 inhibitor in primary breast cancer: Relation to survival, CANCER RES, 60(24), 2000, pp. 6927-6934
Authors:
List, K
Jensen, ON
Bugge, TH
Lund, LR
Ploug, M
Dano, K
Behrendt, N
Citation: K. List et al., Plasminogen-independent initiation of the pro-urokinase activation cascadein vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice, BIOCHEM, 39(3), 2000, pp. 508-515
Authors:
Stephens, RW
Nielsen, HJ
Christensen, IJ
Thorlacius-Ussing, O
Sorensen, S
Dano, K
Brunner, N
Citation: Rw. Stephens et al., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis, J NAT CANC, 91(10), 1999, pp. 869-874
Authors:
List, K
Hoyer-Hansen, G
Ronne, E
Dano, K
Behrendt, N
Citation: K. List et al., Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology, J IMMUNOL M, 222(1-2), 1999, pp. 125-133
Citation: H. Gardsvoll et al., Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis, J BIOL CHEM, 274(53), 1999, pp. 37995-38003